Loading
A phase 1/2 trial in pancreatic cancer, run by M.D. Anderson Cancer Center, now recruiting.
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation is a phase 1/2, interventional study registered as NCT03608631 by M.D. Anderson Cancer Center, with a registry enrolment figure of 28 participants, started 2021-01-27 and due to reach its primary completion in 2027-04-30. Interventions recorded: Mesenchymal Stromal Cells-derived Exosomes with KRAS G12D siRNA. Conditions listed: KRAS NP_004976.2:p.G12D; Metastatic Pancreatic Adenocarcinoma; Pancreatic Ductal Adenocarcinoma; Stage IV Pancreatic Cancer AJCC v8. Primary outcome: Maximum Tolerated Dose Determined by Dose Limiting Toxicity; Minimal residual disease rate in high-risk patients; Overall survival (OS). Pancreatic eligibility wording from the registry: "* Patients with histologically confirmed metastatic pancreatic ductal adenocarcinoma harboring KrasG12D mutation". Sites: United States. No results are recorded here; the registry entry is the source.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.